Fig. 3
From: SKA1 promotes malignant phenotype and progression of glioma via multiple signaling pathways
Suppression of SKA1 expression inhibited tumorigenicity of glioma cells in vivo. a When compared with PLV-Ctr group, tumorigenicity of shSKA1-U87 cells was markedly reduced in vivo (*P < 0.05). b, c Representative IHC images of N-Cadherin, E-Cadherin, MMP9 and PCNA staining in subcutaneous xenografts derived from indicated cells. Graphic representation scoring of indicated biomarkers expression (*P < 0.05). Original magnification ×400